[225Ac]-AZD2284

AZD2284 · AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [225Ac]-AZD2284, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]